Second act for HER2, in gastric cancers - CAP TODAY
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows | BMC Medical Genomics | Full Text
Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH - ScienceDirect
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/9-Figure3-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/ CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer | Virchows Archiv
Update to ASCO/CAP Guideline in Breast Cancer: No Sweeping Changes, but Many Refinements - Cancer Therapy Advisor
ASCO/CAP Guidelines To Determine ER Status May Need Rehaul - General Surgery News
ASCO-CAP HER2 Test Guideline Recommendations PDF | PDF | Immunohistochemistry | Metastasis
Mapping knowledgebase-specific evidence codes to AMP/ASCO/CAP... | Download Table
ASCO/CAP immunohistochemical HER2 evaluation protocol (2007) | Download Table
ASCO 2022 – Standing ovation and hope. - Cerba Research
Identification of challenges and a framework for implementation of the AMP/ ASCO/CAP classification guidelines for reporting somatic variants - ScienceDirect
ASCO 2020: HER2 Reclassification - Agendia Inc.
Oncology Times
CACSV
HER2 spectrum of expression according to ASCO/CAP guidelines. HER2-low... | Download Scientific Diagram
Breast cancer biomarkers, and a new clinical category for HER2 expression | Medical Laboratory Observer
What's New in the 2020 Update to the CAP/ASCO ER/PR Testing Guidelines in Breast Cancer?
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect
Summary of ASCO/CAP HER2 testing recommendations 2007 and 2013 | Download Table
Q&A column - CAP TODAY
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows | BMC Medical Genomics | Full Text
HER2 Status Determined by 2007 and 2013 ASCO/CAP Criteria, Respectively... | Download Table
![PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b66331181b2eafa14b6e478dcc7fced0c7917993/3-Table1-1.png "PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar")
PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar
